Reaction
New Onset Refractory Status Epilepticus reporting signals
As of the last recalculation, New Onset Refractory Status Epilepticus appears in 105 FAERS reports alongside 17 co-occurring drug terms. The strongest observed disproportionality signal is BRIVARACETAM (PRR 1,060.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Brivaracetam | 33 | 1,060.4 | 1,064.3 |
| Lacosamide | 55 | 614.2 | 615.1 |
| Phenobarbital | 29 | 547.7 | 548.8 |
| Midazolam Hydrochloride | 40 | 475.1 | 475.8 |
| Phenytoin | 31 | 417.4 | 418.1 |
| Midazolam | 35 | 412.4 | 413.0 |
| Propofol | 39 | 336.1 | 336.4 |
| Levetiracetam In Sodium Chloride | 56 | 305.9 | 306.1 |
| Levetiracetam Oral | 56 | 305.9 | 306.1 |
| Levetiracetam Injection | 56 | 305.8 | 306.0 |
| Valproic Acid | 31 | 276.3 | 276.5 |
| Piperacillin Sodium,Tazobactam Sodium | 27 | 271.3 | 271.5 |
| Clobazam | 22 | 225.7 | 225.9 |
| Lamotirigine | 45 | 217.2 | 217.3 |
| Lamotrigine Extended-Release | 45 | 217.2 | 217.3 |
| Lamotrigine Chewable Dispersible | 45 | 217.2 | 217.3 |
| Piperacillin And Tazobactam | 10 | 171.2 | 171.3 |